On February 23, 2019, President Zhang Baoxian of Increase Innovation Medicine (IIM) visited HKAP. Increase Innovation Medicine is a high-tech enterprise located in Beijing focusing on innovative drug research and development. After deep communication and exchange on Aptamer-based drug discovery, IIM and HKAP have arrived at Strategic Cooperation Agreement on developing the next generation of smart drugs.
Prof. Zhang Ge (HKAP), Dr. Wang Fang (IIM), Dr. Dong Changqing (IIM) and Dr. Kang Zhiyun (IIM) discussed the Specific Cooperation Framework of the agreement in accordance with the principle of equity and free will, and common development.
